News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Halts Hepatitis C Drug Trial After Death


4/20/2012 7:12:03 AM

ZURICH – Novartis AG (NVS) said Thursday the development program of an experimental drug for the treatment of Hepatitis C has been placed on hold by U.S. regulators after the death of a patient, which may be linked the drug. A small number of patients treated with the DEB025 drug or alisporivir developed pancreatitis, which is believed to be a contributing factor to the death, Novartis said.

Read at Wall Street Journal
Read at Fox News
Read at Canadian Business
Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES